Early Onset Sepsis in Newborns: Recognizing the Signs and Symptoms

Early onset sepsis (EOS) remains a critical concern in neonatal care, occurring within the first 72 hours of life. Prompt recognition of subtle symptoms is essential for timely intervention and improved outcomes.

Recent Trends

In recent years, clinical focus has shifted toward more judicious use of antibiotics in newborns while still identifying at-risk infants early. Updated screening algorithms now emphasize risk stratification based on maternal history and serial clinical assessments rather than universal lab testing. Additionally, antibiotic stewardship programs in neonatal intensive care units (NICUs) have gained prominence, aiming to reduce unnecessary exposure and prevent antimicrobial resistance.

• Adoption of multivariate risk calculators (e.g., Kaiser-Permanente model) in many centers
• Increased emphasis on serial physical exams and vital sign monitoring
• Growing use of early biomarkers (e.g., procalcitonin, CRP) as adjuncts but not sole decision-makers

Background

Early onset sepsis is typically defined as a bloodstream infection occurring within the first three days of life. Common causative pathogens include Group B Streptococcus (Streptococcus agalactiae) and Escherichia coli. Transmission often occurs vertically from mother to infant during labor or delivery. Key risk factors include:

• Maternal colonization with Group B Streptococcus (GBS) without adequate intrapartum prophylaxis
• Prolonged rupture of membranes (generally more than 18 hours)
• Preterm birth (especially before 37 weeks gestational age)
• Intraamniotic infection (chorioamnionitis)
• Low birth weight or very low birth weight

Infection can progress rapidly in newborns due to their immature immune systems. Signs are often nonspecific and may be subtle, making clinical judgment critical.

User Concerns

Parents and caregivers frequently worry about distinguishing normal newborn behavior from early warning signs of sepsis. Common concerns include the difficulty of recognizing changes such as temperature instability, feeding difficulties, or lethargy in a baby who may otherwise appear well. Healthcare providers address this by teaching families to monitor for a combination of symptoms rather than a single sign.

• Temperature: fever (rectal >100.4°F or 38°C) or hypothermia (<96.8°F or 36°C)
• Respiratory: rapid breathing, grunting, nasal flaring, or pauses (apnea)
• Feeding: poor suck, vomiting, or refusal to feed
• Behavior: irritability, high-pitched cry, or unusual sleepiness
• Circulation: pale or mottled skin, delayed capillary refill, or low blood pressure

A key diagnostic challenge is the overlap of these signs with benign conditions (e.g., temporary tachypnea of the newborn) or other serious disorders (e.g., congenital heart disease). Therefore, clinicians rely on a combination of maternal history, physical examination, and selective lab testing to guide decisions.

Likely Impact

When recognized and treated promptly, the prognosis for most neonates with EOS is favorable with appropriate antibiotics and supportive care. However, delayed intervention can lead to severe complications including meningitis, respiratory failure, shock, or long-term neurodevelopmental impairments. The use of standardized screening protocols has been shown to reduce both unnecessary antibiotic use and missed cases. Nevertheless, no single test perfectly predicts infection, so a low threshold for initiating treatment in high-risk infants remains standard practice.

What to Watch Next

Ongoing areas of development include the refinement of clinical decision aids that integrate real-time electronic health record data, as well as point-of-care biomarker tests that may provide results within minutes. Researchers are also evaluating the role of molecular diagnostics (e.g., PCR panels) to identify pathogens rapidly. Additionally, telemedicine-based consultations for rural or community hospitals may improve access to neonatal expertise. Guidelines from major pediatric organizations are periodically updated, so clinicians and families should stay informed about any changes in prevention strategies, such as intrapartum antibiotic prophylaxis recommendations or the use of risk-based versus culture-based approaches.